Hennessy Advisors Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,400
Closed -$3.14M 291
2022
Q1
$3.14M Buy
+6,400
New +$2.93M 0.16% 191
2019
Q2
Sell
-13,000
Closed -$3.73M 294
2019
Q1
$3.73M Sell
13,000
-1,000
-7% -$289K 0.17% 150
2018
Q4
$3.68M Sell
14,000
-1,600
-10% -$440K 0.18% 139
2018
Q3
$4.28M Sell
15,600
-500
-3% -$130K 0.16% 155
2018
Q2
$3.83M Sell
16,100
-1,000
-6% -$232K 0.13% 170
2018
Q1
$3.76M Buy
+17,100
New +$4.02M 0.13% 179

Other funds holding ELV

Hennessy Advisors Inc's ELV Position: Q2 2022 in Review

Hennessy Advisors Inc sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 6,400 shares — an estimated $3.14M sold.

Hennessy Advisors Inc first reported a position in ELV in Q1 2018 and held it in 6 quarters. The position peaked at $4.28M in Q3 2018. 1,442 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Hennessy Advisors Inc reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Hennessy Advisors Inc sold 6,400 Elevance Health shares in Q2 2022, an estimated $3.14M.
  • Hennessy Advisors Inc first reported a position in Elevance Health in Q1 2018 and held it in 6 quarters.
  • Hennessy Advisors Inc's Elevance Health position peaked at $4.28M in Q3 2018.
  • 1,442 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Hennessy Advisors Inc's 13F filing for Q2 2022, filed 12 Aug 2022.